Skip to main content
. 2022 Apr 7;59(4):2100972. doi: 10.1183/13993003.00972-2021

FIGURE 5.

FIGURE 5

Relative change from baseline (geometric mean (Gmean) ratios) in objective cough count for day 14 over a) 0–4 h post-dose, b) 0–12 h post-dose and c) 0–24 h post-dose. UMEC/VI: umeclidinium/vilanterol.